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Abstract
This paper provides an international perspective on the use of medications to treat 
problematic sexual interests, paraphilic disorders and sexual preoccupation in men 
who have committed a sexual offence. Experts from Canada, Czech Republic (CR), 
Russia, United Kingdom (UK), and the United States of America (US) met in Prague, 
CR in May 2017 to review and compare their treatment approaches. This report is a 
summary of their discussions, including empirical data from CR and Russia which 
have not previously been published in the English language. All participants agreed 
that continuing international collaboration would be very useful for the 
development of ethical international prescribing guidelines, as well as pooling data 
from studies on the efficacy and utility of pharmacological and other biological 
treatments for people who have committed sexual offences. 
Keywords: anti-androgen; sexual offending; treatment effectiveness; paraphilic 
disorder; selective serotonin uptake inhibitors (SSRIs)
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Introduction
Sexual thoughts or behaviors which can cause harm to self and/or others fall into 
three categories. The first category includes adults with a sexual interest in 
anomalous sexual targets (such as non-human animals or children), or atypical 
sexual behaviors (such as voyeuristic or sadistic activities). These types of sexual 
interest are classified as paraphilias and/or paraphilic disorders in the latest edition 
of the International Classification of Diseases (ICD-11, WHO, 2018) and the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5, American Psychiatric 
Association, 2013). To be diagnosed as a paraphilic disorder, the sexual interest must 
persist for at least six months and be accompanied by clinically significant distress or 
functional impairment, or have been acted upon (DSM-5, p. 698). Functional 
impairment may include interference with healthy sexual behavior: for example, the 
paraphilic disorder of Sexual Sadism may impair a person’s capacity to maintain a 
fulfilling sexual and emotional relationship with a consenting partner. Alternatively, 
paraphilic disorders may create emotional distress, a sense of isolation, and feelings 
of stigma and shame for the individual concerned (Levenson& Grady, 2017).  If acted 
upon, many paraphilic interests have the potential to cause harm to self or others, 
including the commission of sexual offences.
A second area of problematic sexuality relates to excessive sexual thought content, 
which has been termed sexual preoccupation or hypersexual cognition. Sexual 
preoccupation has been described by Mann, Hanson and Thornton (2010) as “an 
abnormally intense interest in sex that dominates psychological functioning” (p.198). 
It has been described as a condition in which unwanted sexual thoughts “fill one’s 
headspace, leaving little room for anything else” (Lievesley, Elliott, Winder, Norman 
& Kaul, 2014). Sexual preoccupation can present as an obsessive-compulsive 
condition, in which the individual struggles against unwanted and intrusive sexual 
thoughts (Kalichman et al, 1994). This has been likened to a song being played 
loudly and repeatedly, drowning out all other sounds (Winder, 2018).
The third category of problematic sexual functioning has been described as 
engagement in an excessive number of impersonal sexual acts (Langstrom et al, 
2006). This engagement in excessive sexual behaviors was first labelled as 
“hypersexual” by Krafft-Ebing in 1905. Further work was conducted on 
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hypersexuality by Kinsey, Pomeroy and Martin (1948), who performed studies of 
hypersexual behavior in the general population. They reported that 7.6% of their 
male sample (n=14,083) regularly had a total sexual outlet (TSO) of seven or more 
orgasms per week, which they designated as statistically ‘high’. More recent research 
has found this figure to be increasing: 12.1% of a community male sample (n=8718) 
had a TSO of at least 7.0 (Klein, Schmidt, Turner & Briken, 2015). Some have argued 
that frequency of intimate or impersonal sexual activity should not be clinically 
concerning in and of itself, provided the people involved are consenting (Fedoroff, 
2016). However, relatively high or low frequencies of sexual activity, including 
impersonal sexual behavior in particular, may seem problematic for an individual 
patient.
These three aspects of problematic sexual functioning (deviant sexual interest, 
hypersexual cognition, and hypersexual behavior) each represent potential ways to 
understand individuals who have committed a sexual offence, or who are concerned 
that they may do so. They are each considered problematic since they may be 
associated with distress in self or others, functional impairment, and/or the 
commission of sexual crimes. It should be noted that the DSM-5 does not list 
“hypersexuality” as a disorder. The Canadian author in this paper (PF) reframes 
complaints of this type as “sexual frustration”, i.e. not inherently pathological, and 
treatable via facilitation of consensual sexual activities. Nevertheless, the other 
authors of this paper consider the concept to be a useful heuristic that identifies a 
clear treatment target.
Problematic sexual behaviors are  linked to a number of deleterious consequences, 
including increased risk of sexually transmitted infections (Yoon et al., 2016), 
physical injuries (Carnes, 1991), job loss (Paunović & Hallberg, 2014), financial losses 
(Reid et al., 2012), interpersonal problems (Winder et al, 2014; 2017; Lievesley et al, , 
2014), breakdown of relationships (Paunović & Hallberg, 2014), feelings of social and 
emotional isolation (Winder, 2017), depression (Walton et al, 2017), increased anxiety 
(Walton et al, 2017), substance abuse (Opitz, Tsytsarev, & Froh, 2009), legal penalties 
for sexual harassment (Reid, Carpenter, & Lloyd, 2009) and sexual offense 
recidivism (Hanson& Morton-Bourgon, 2005). Sexual preoccupation has also been 
suggested as a factor in treatment ineffectiveness for people who have committed a 
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sexual offence (Grubin, 2018), causing interference in their capacity to focus and 
engage in psychological treatment (Winder et al, 2017). 
It is important to distinguish between genetics, gender, sexual orientation, sexual 
drive and sexual interests, as each of these has implications for understanding the 
nature of the problem and its treatment. In treatment centres that have not found it 
possible for patients to change unwanted sexual interests (e.g., attraction to children 
or genital exhibitionism), there are forms of therapy which may facilitate acceptance 
of arousal patterns that they feel unable to control, such as compassion-focused 
therapy (Gilbert, 2014). Likewise, medications may help reduce unwanted sexual 
urges which have not been controllable otherwise for patients currently receiving 
psychotherapeutic treatment, as well as those who have not completed treatment.
Medication to manage problematic sexual functioning
Cognitive-behavioral therapy (CBT) has been the main modality of 
psychotherapeutic treatment for people convicted of sexual offences in the UK since 
the 1990s (Lievesley et al, 2013). Systematic use of medication only began to emerge 
in the early 2000s, including a program of voluntary medication at HMP Whatton, 
Nottinghamshire since 2009 (Winder et al, 2014). In both the US (Hanson et al, 2002) 
and CR (Weiss, 2017), CBT remains the primary psychotherapeutic approach for 
people convicted of sexual offences.  In Canada, psychotherapeutic treatment for sex 
offenders has been augmented with medications (Guay, 2009), following the 
Marques study that suggested CBT alone was ineffective in the treatment of 
incarcerated sex offenders (Marques 2005; Fedoroff & Marshall, 2010).  In Russia, 
medication remains the primary means of treating people with sexual convictions 
(Kamenskov, 11 October 2018, personal communication), although other means 
(such as occupational therapy and counselling) may also be employed. 
Medication treatment for sexual offenders is voluntary in the majority of countries. 
In Poland, however, pharmacological treatment may be mandated by court order for 
anyone found guilty of having sexually abused a child under the age of 15 years 
(McAlinden, 2012). In some European countries, pharmacological treatment can be 
administered as a formal condition of parole (Turner, Petermann, Harrison, Krueger 
& Briken, 2017). In Canada, while the courts are not permitted to prescribe 
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medication, courts may set conditions requiring an individual to comply with the 
treatment recommendations of his physician.
The available evidence suggests that medication treatment can be effective for 
people who have committed sexual offences, but there are differences of opinion 
within and between countries concerning the definition of efficacy, and how it 
should be determined. The use of medication for treating people convicted of sexual 
offences at all has been criticized as ‘medicalizing’ sexual offending, thereby 
absolving perpetrators of sexual crime of responsibility (Weston, 2018). Important 
research problems have included low base rates of sexual reoffending, the ethical 
difficulties involved in conducting double-blind studies, and the amount of time 
necessary to conduct prospective treatment evaluations. The efficacy of treatments 
for sex offenders may be assessed in dimensions beyond the reduction of sexual 
recidivism, including deviant or problematic sexual thinking, hypersexual cognition, 
treatment compliance, and patient wellbeing. The latter should encompass both the 
wellbeing of the patient and the putative impact on anyone affected by the patient’s 
actions. The consideration of “wellbeing” in this broader fashion leads to a richer 
evidence base on which to assess the effectiveness of medication treatment.
Clinical criteria and prescribing practice
The three classes of medications most often prescribed for problematic sexual 
behavior include the selective serotonin reuptake inhibitors (SSRIs) and two types of 
testosterone-lowering agents; the anti-androgens and the gonadotropin releasing 
hormone (GnRH) agonists.  Drugs such as the antipsychotics, tricyclic 
antidepressants, anticonvulsants, lithium, buspirone, naltrexone and amphetamines 
have sometimes been used, but the evidence base for them is small and their efficacy 
inconsistent (Thibaut, 2010).
The mode of action of SSRIs to manage problematic sexual arousal and behavior is 
unclear, and it may vary among individuals.  Similar to the effects seen in obsessive 
compulsive disorder, the SSRIs can reduce the frequency and intensity of fantasy, 
rumination and compulsive behavior in patients with psychosexual disorders. They 
may also stabilize mood, reduce impulsivity, and decrease sexual drive (Greenberg, 
2007).  Anti-androgens and GnRH agonists both reduce testosterone to pre-pubertal 
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levels, leading to reduction or elimination of sexual drive and interest, although they 
act through different mechanisms. The GnRH agonists reduce pituitary 
gonadotropic hormones, are more potent, and have fewer side effects. The side effect 
profile (discussed later in this paper) needs to be balanced with the goals of 
treatment, including reduction in reoffending risk and improvement in wellbeing. 
Testosterone-lowering medications are used primarily to treat men with prostate 
cancer, and many physicians are unfamiliar with their use for the purpose of 
controlling sexual drive, and reluctant to prescribe them for this reason.  
A variety of articles have been published in recent years which provide 
recommendations for the prescription of medications for problematic sexual 
behavior, including which patients are most appropriate for consideration of this 
treatment, as well as specific indications and dosages (Garcia, 2013; Holoyda, 2016; 
Turner, 2018; Assumpcao, 2014; Murphy, Bradford & Fedoroff, 2014). The most 
comprehensive review of pharmacologic treatment for paraphilic disorders was 
published almost a decade ago (WFSBP, 2010), and are currently undergoing 
revision. The 2010 WFSBP guidelines conclude that “…little is known about which 
treatments are most effective, for which offenders, over what duration, or in what 
combination” (p. 644).”The guidelines propose a hierarchical treatment protocol in 
which treatment is largely based on risk, and progresses from psychotherapy 
(offered at all stages) to an ultimate stage where the paraphilic disorder is 
considered “catastrophic” (i.e., can result in serious injury or death). At this most 
severe stage, the combination of a GnRH agonist with an antiandrogen and/or SSRI 
is recommended. It should be noted that the WFSBP guidelines indicate that 
paraphilias should be considered “chronic disorders,” and that “sexual orientation 
will not change during treatment” (p. 648). However, the view that paraphilias are 
necessarily chronic and that paraphilias are “orientations” has been challenged 
(Fedoroff, 2018).
While not specifically mentioned, the WFSBP guidelines appear to follow a “risk, 
needs, responsivity” (RNR) paradigm, in which the intensity of treatment is 
increased as the apparent risk of sexual recidivism increases. This is described in a 
table that grades paraphilic severity from one to six depending on victim impact, 
and links treatment to level of paraphilic severity, starting with psychotherapic 
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treatment alone. However, many therapists consider LHRH agonists preferable to 
anti-androgens whenever a testosterone lowering medication is indicated – their side 
effect profile appears to be relatively milder, and their effect more consistent than 
oral anti-androgens. LHRH agonists are only available by intramuscular injection, 
while anti-androgens are available in oral and intramuscular formulations. 
The Sexual Behaviours Clinic (SBC) protocol at the Royal Ottawa Mental Health 
Centre in Canada, developed by Fedoroff and team, does not adhere to the WFSBP 
guidelines and is more patient-oriented. Patients are presented with a range of 
treatment options and given the choice about which treatment intervention they will 
receive.  This is done in an educational manner, with emphasis on consent and 
improvement in the patients’ lives, including their sex lives. Patients are told that the 
suppression of sexual drive induced by anti-androgens and GnRH analogues is 
reversible, and that treatment with these medications is only temporary, while 
working in conjunction with the treatment team that helps them to normalize their 
lives, including their sexual interests. SSRIs are never used in the SBC to suppress 
sexual drive, since this can be done more effectively with antiandrogens and GnRH 
analogues. In addition, SSRI medications are associated with inhibited orgasm in a 
dose-dependent fashion (Clayton, 2014). When used at the doses recommended by 
the WFSBP guidelines, there is the danger that a patient may resort to paraphilic 
fantasy or behavior in order to facilitate orgasm. This is counterproductive to the 
goal of treatment, which is to replace paraphilic interests with sexual fantasies and 
behaviors that do not cause distress or impairment, and do not increase the risk of 
criminal activity or harm to self or others (Murphy et al, 2014; Fedoroff, 2016). In 
addition, the SBC conceptualizes paraphilic disorders as being based in problematic 
sexual interests that can be modified, as opposed to the WFSBP’s assumption that 
they are immutable “orientations”(Fedoroff, 2018).
In addition to the WFSBP and SBC models, a third medication treatment model is 
followed by the British Association of Psychopharmacology (BAP) in the UK, which 
focuses on medical indication rather than risk (Grubin et al, in preparation):
 SSRIs are recommended as an initial intervention when individuals report 
high levels of preoccupation, rumination or impulsive behavior, or when 
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problematic sexual behavior appears to be associated with dysfunctional 
mood states;
 Anti-androgens and GnRH agonists are prescribed as the initial intervention 
when the primary indication is hypersexual behavior, or when the individual 
subjectively describes difficulty in managing his or her sexual drive. 
Thus, in the UK protocol, even the most ‘high risk’ individual with a sexual 
conviction may be prescribed an SSRI at the start of treatment, while an anti-
androgen or GnRH agonist may be indicated in a ‘low risk’ individual presenting 
with hypersexual behavior that is causing distress. The UK protocol, like the SBC, 
gives patients the choice of medication once the effects and side effects are 
explained.  While the issues associated with SSRIs noted by the SBC are recognised, 
the UK experience is that their milder side effect profile tips the balance in their 
favor; for this reason, many patients opt for them over hormonal treatment.  
Evaluations of the UK protocol have found SSRIs to be effective and well tolerated, 
with typical dosages commencing at 20 mg of fluoxetine, increasing to 40 - 60 mg 
daily (Winder et al, 2014; 2017).
The WFSBP guidelines are generally followed in the Czech Republic (CR), although 
Czech sexologists strictly differentiate between paraphilic and nonparaphilic service 
users. This diagnosis is established based on sexological, psychiatric, and 
psychological assessments including penile plethysmography. In agreement with the 
WFSBP, paraphilic orientation is considered to be stable and life-long, resulting from 
congenital or early developmental conditions. The goals of treatment include 
reduction of sexual drive using anti-androgens or GnRH agonists as appropriate, as 
well as fostering alternative ways to meet sexual needs using socially acceptable 
forms of sexual behavior. Voluntary surgical castration maybe offered to patients 
under strictly controlled conditions (Weiss, 2017). 
Is pharmacological treatment effective?
The most recent Cochrane review (Khan, Ferriter, Huband, Powney, Dennis & 
Duggan, 2015) examined the effectiveness of pharmacological interventions for 
people who have committed a sexual offence. Their review outlined only seven 
small trials, mainly from the US and all published more than 20 years ago, with no 
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large-scale or controlled studies included. Grubin (2006) had previously attempted a 
randomised controlled trial to evaluate the effectiveness of pharmacological 
interventions, but because the prison service was just commencing its treatment 
programme for offenders with problematic arousal, the study was unable to attract a 
sufficient sample size and had to be discontinued. Winder, Norman, Lievesley and 
Kaul (2018) have presented findings from an unmatched control study of the 
effectiveness of SSRIs and anti-androgens on 247 prisoners serving custodial 
sentences for a sexual offence. Statistically significant reductions were demonstrated 
for the SSRIs both pre- and post-medication, while the control group did not 
demonstrate a statistical reduction. However, there were methodological difficulties 
with the control group (see Winder et al, in preparation). A randomised controlled 
trial would be a helpful next step in building upon the Cochrane review, examining 
the evidence for each type of medication in reducing problematic sexual arousal, 
both statistically and clinically. An important issue in all effectiveness studies is the 
outcome measure used. In Winder et al (2018), outcome measures included the 
Sexual Compulsivity Scale (Kalichman et al, 1994), the Warwick Edinburgh Mental 
Wellbeing Scale (WEMWBS; Stewart-Brown & Janmohamed, 2008) and clinical 
measures developed by Grubin and others (2008) concerning masturbation, sexual 
preoccupation and ability to distract self from sexual thoughts. 
How can effectiveness be assessed?
In Russia, studies were conducted by Vvedensky et al (2011) on 80 adult males who 
had committed sexual offences and had been sentenced by court order to 
compulsory treatment. All participants had been admitted as sufficiently severely 
mentally disordered as to be classified as legally certifiable.  In this regard, 39 of the 
participants were also diagnosed with paranoid schizophrenia, 23 with organic 
personality disorder and 18 with an intellectual disability. These mental disorders 
were in most cases combined with alcohol or drug dependence. Two groups of 
patients were identified, including one which comprised 52 patients with paraphilias 
(25 with pedophilia and 27 with multiple deviant sexual preferences), and a second 
group of 28 patients who were non-paraphilic, but had been diagnosed with 
hypersexual disorder. All patients had been receiving ten years of complex 
psychotropic medication treatment based on their individual diagnoses, including 
antidepressant, mood-stabilizing, and/or antipsychotic drug classes. Specific agents 
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included SSRIs, lithium, carbamazepine, zuclopenthixol, amisulpride, risperidone, 
and/or pericyazine. All patients received testosterone-lowering medication to reduce 
sexual drive, including an average biweekly intramuscular dose of 300mg of 
Cyproterone Acetate (Androcur depot). Side effects in the first month included 
tiredness, apathy, drowsiness, a feeling of lack of air, and hot flushes for 
approximately a third of patients. Reported side effects after one to three months 
included depression, anxiety, nervousness and agitation in approximately 15% of 
participants. Gynecomastia appeared in 8.75% after six months of treatment.  After 
eight months of treatment, metabolic and alimentary disorders were reported in just 
under a quarter of participants. 
In the first group of paraphilic patients, treatment led to improvement in the mental 
and psychosexual state of 63.5%, while only 50% of patients in the second group of 
hypersexual patients showed similar improvement. In the paraphilic group, 75% had 
significant reactions on the polygraph to questions regarding abnormal fantasies or 
their specific offences at baseline, decreasing to 46% when tested again after two to 
six years. Improvements were also noted in both groups on psychometric testing, 
with 55.6% of paraphilic patients and 44% of hypersexual patients improved, 
respectively. These improvements were characterized by more positive self-
perception, greater self-identification with the image of “being a man" a more 
differentiated female gender role, more androgynous gender-role behavior, and 
more cooperative personality traits. These results indicate that psychophysiological 
and psychological methods can assist in assessing the effectiveness of 
pharmacological treatment for individuals convicted of sexual offences. 
Castration
While the use of testosterone-lowering medications is sometimes referred to as 
“chemical castration,” this term is inappropriate since the effects are temporary and 
vary according to type of medicine and dosage used. Surgical castration (bilateral 
orchiectomy) is an irreversible procedure involving the removal of the testes or 
testicular parenchyma, leading to a reduction in the level of circulating sex 
hormones, and subsequent diminution of libido (Zvěřina et al., 1991). The practice of 
surgical castration raises important ethical and legal questions (e.g. van der Meer, 
2014; Stojanovsky, 2011). For example, opponents of surgical castration question the 
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extent to which people can voluntarily submit to this irreversible procedure (Heim & 
Hursch, 1979).  Advocates emphasise the proven efficacy of the procedure, the fact 
that it is a logical voluntary treatment choice for many patients and their caregivers, 
and that it provides patients with better behavioral control and the possibility of 
greater independence from the healthcare system since there is no need for 
continued pharmacologic treatment to lower testosterone (Krueger, 2009).
Castration in the Czech Republic
The Czech Republic (CR) is one of the few countries where voluntary surgical 
castration can be offered to a patient under strictly controlled conditions, and only 
by patient request. The procedure is very rarely utilised and is kept as a voluntary 
option mainly for patients for whom other medical therapy is contraindicated. Since 
2012, only two patients with paraphilic disorders have undergone surgical castration 
in the CR (Weiss, 2017). The more frequent previous usage of surgical castration in 
the CR, together with questions from the European Committee for the Prevention of 
Torture (CPT, 2009), prompted a retrospective study by Zvěřina, Weiss and Hollý 
(2014) which has never before been presented in the English language literature. 
This study focused on the effectiveness and impact of surgical castration on patients´ 
well-being, and surveyed doctors and patients from all inpatient and outpatient 
departments in the CR which provide sexological treatment. Sexologists reported 
through structured interviews on the psychological health issues and sexual 
recidivism of their patients. Patients filled out a survey questionnaire which focused 
on a retrospective assessment of their post-castration adjustment. The questionnaire 
asked patients anonymously about the perceived utility and voluntariness of the 
procedure, together with subjective ratings of patients’ somatic/psychological states 
following castration. The responses of doctors concerning 50 castrated individuals 
were collected (mean age = 42.8 years, SD=10.5 years). The mean time from castration 
was 31.5 years (SD = 10.6). ICD-10 diagnoses at the time of castration included 
pedophilic disorder (n=18; 36%), sexual sadism (n=17; 34%), and pathological sexual 
aggression (n=15; 30%). These patients represented 53.2% (n = 50/94) of individuals 
who had committed a sexual offence and had undergone surgical castration in the 
CR between 1998 and 2008 (CPT, 2009). 
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Doctors’ responses
Sexual recidivism was reported in two cases (4%). Medication side effects included 
loss of body/facial hair (38%), significant weight gain (36%) or weight loss (20%), 
gynecomastia (16%), and tiredness (18%). Some degree of osteopenia was found in 
all patients who underwent testing of bone density (n=34). Psychological side effects 
were also attributed to the medication, including depressive symptoms (16%), 
feelings of inferiority (13%), irritability and emotional instability (20%), and feelings 
of isolation (16%). No adverse psychological effects were observed in 50% of cases.
Patients’ responses
Satisfaction with somatic (n=35; 81%) and psychological (n=38; 88%) wellbeing was 
quite high. Satisfaction with sex life was more ambivalent (n=26; 60%). A range of 
sexuality-related issues were reported, including complete loss of sex drive in 16 
patients (32%), erectile dysfunction in 17 patients (34%), and problems with orgasm 
in 12 patients (24%). There were no differences in suicidal tendencies, relationship 
stability, employment levels, or commission of non-sexual crimes either before or 
after intervention. The majority reported that their decision to undergo castration 
was voluntary (n=38; 88%), and 26 individuals (60%) asserted they would 
voluntarily undergo surgical castration again. The study confirmed the effectiveness 
of surgical castration, but also highlighted a wide spectrum of somatic and 
psychological side effects. 
Russia
Surgical castration for the treatment of sexual offenders is currently illegal in Russia. 
According to Article 11 of the “law on psychiatric care and the safeguarding of 
citizens' rights in the dispensing of such care” (Russian Federation, 1992), surgical 
castration and other irreversible methods are prohibited for the treatment of mental 
disorders.
Canada, UK and US
In Canada, the UK and the US, surgical castration is not currently used as part of any 
official sex offender treatment programs and is not involuntarily imposed on 
individuals. Some patients seek and obtain this treatment voluntarily, usually after a 
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successful trial of antiandrogen therapy, and in collaboration with a professional 
specialising in the area (see Saleh, Niel & Fishman, 2004). 
Europe (not including UK)
Most studies on the efficacy of castration in reducing sexual recidivism were 
conducted in Europe, particularly Germany and Denmark, and these documented 
the long-term efficacy of bilateral orchiectomy for most patients (i.e., less than 5% 
recidivism). These patients were described as dangerous and severely paraphilic, 
serial contact offenders. Meta-analytic reviews have reported very low recidivism 
rates of 0-10% in patients who underwent surgical castration (Weinberger et al. 
2005), and a much stronger effect on decreasing sexual recidivism in comparison 
with other forms of medical treatments (Lösel & Schmucker, 2005), but they point to 
a variety of methodological limitations in these studies. 
Conclusions
The intent of this paper was to summarize three days of intensive discussions among 
a group of international practitioners and researchers regarding the pharmacologic 
treatment of problematic sexual interests, paraphilic disorders, and sexual 
preoccupation in adult men who have committed a sexual offence. It became clear 
that there were significant differences among the participants and countries 
involved, including the definition of what constitutes a problem of sexual interest or 
behavior that needs to be treated, whether the treatment must be voluntary, what 
medications are used, the measures of efficacy, and even whether paraphilic 
interests can be changed. Not surprisingly, experts also differed in terms of specific 
psychotherapeutic interventions. However, in spite of these differences, there were 
many areas of consensus. Antidepressant medications were widely used, although 
the reasons for this varied, with some focusing on treatment of concurrent 
psychiatric disorders (anxiety, depression, sleep disorders), and others focusing on 
reduction of sexual drive. Testosterone-lowering medications were widely accepted 
as useful in reducing sex drive, at least temporarily, including both antiandrogens 
and GnRH agonists. Not reviewed in this paper was the wide difference in the cost 
and availability of GnRH medications, which undoubtedly affects how often they 
are prescribed. 
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Unlike many psychiatric disorders that remain out of the public eye, psychiatric 
disorders associated with sex crimes are understandably high profile because they 
cause harm to others. Societal responses to those who commit sexual offences, and 
especially those who are found to be statistically likely to reoffend sexually, appear 
to be growing more extreme and more punitive (Blagden & Perrin, 2016). Even when 
individuals seek help to reduce their risk of reoffending, they may be targeted by 
media and subjected to extreme reactions, and this public fear and panic tends to 
drive irrational decision-making (Fox, 2013; Harper & Hogue, 2015).
It is important for researchers and clinicians to work collaboratively to demonstrate 
the efficacy of current and new treatments. This can be facilitated by meeting like the 
one held in Prague in May 2017, in which experts can challenge each other’s 
assumptions and paradigms, combine and compare data, and plan interventions and 
investigations. Sexual crime is an international problem, and attempts to solve, 
reduce and prevent this problem should also be global.
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